Diet and lifestyle interventions for obese pregnant women  by Thangaratinam, Shakila
Comment
748 www.thelancet.com/diabetes-endocrinology   Vol 3   October 2015
Diet and lifestyle interventions for obese pregnant women
Improvem ent of health outcomes in obese and 
overweight individuals is a worldwide research priority. 
Lifestyle interventions in pregnancy have the potential 
to minimise complications in both mother and baby.1 
In The Lancet Diabetes & Endocrinology, Lucilla Poston 
and colleagues in The UPBEAT Trial Consortium2 report 
ﬁ ndings of one of the largest randomised trials to date 
to assess the eﬀ ects of lifestyle interventions in obese 
pregnant women.
In the UPBEAT study, Poston and colleagues assessed 
a complex behavioural intervention based on a healthy 
diet and increased physical activity and compared it with 
standard antenatal care in the UK. The study focused 
primarily on the incidence of gestational diabetes and 
large-for-gestational-age babies; the authors also 
assessed other clinically important outcomes such as 
pre-eclampsia, mode of delivery, and preterm birth, 
as well as neonatal outcomes, maternal and fetal 
weight-related outcomes, glycaemic status, dietary 
intake, and measures of physical activity. 
The intervention in obese pregnant women did 
not reduce the incidence of gestational diabetes (risk 
ratio 0·96, 95% CI 0·79–1·16; p=0·68) or large-for-
gestational-age babies (1·15, 0·83–1·59; p=0·40). 
No diﬀ erences between groups were noted for several 
of the other clinical outcomes, measures of glycaemic 
status (including blood glucose concentrations), or 
the need for insulin. Total gestational weight gain was 
lower in the intervention group than in controls (mean 
diﬀ erence –0·42 kg, 95% CI –0·75 to –0·09; p=0·013), 
an eﬀ ect seen by 28 weeks of gestation. In women who 
received the intervention, a signiﬁ cant improvement 
was reported in dietary pattern, and physical activity was 
also increased. 
The UPBEAT trial has added to growing evidence 
showing the ineﬀ ectiveness of mixed interventions 
based on diet and lifestyle on the incidence of 
gestational diabetes and large babies, particularly in 
overweight and obese women. The study ﬁ ndings 
accord with those of previous systematic reviews,3 
in which mixed interventions based on both diet 
and physical activity did not reduce the incidence of 
gestational diabetes. Interventions based mainly on 
diet, some with restricted energy intake, have shown a 
beneﬁ cial eﬀ ect in prevention of gestational diabetes.1 
However, the studies were small and did not assess 
gestational diabetes as a primary outcome. 
The LIMIT trial, which included overweight and obese 
pregnant women, also reported no beneﬁ cial eﬀ ect of 
diet and physical activity on large-for-gestational-age 
fetuses or gestational diabetes.4 In a Cochrane review,5 
a reduction in excess weight gain during pregnancy 
was reported with diet and lifestyle interventions, but 
gestational diabetes was not assessed as an outcome. 
Although a lower weight gain was noted in the 
intervention group compared with standard care by 
28 weeks of gestation in the UPBEAT study, this ﬁ nding 
did not translate into clinical beneﬁ ts. 
Poston and colleagues noted a possible reluctance 
of obese women to follow the intervention, with only 
a ﬁ fth of all eligible mothers participating in the trial. 
Whether women with a previous history of gestational 
diabetes will be more willing to adopt the planned 
intervention, or whether there will be a diﬀ erential eﬀ ect 
in this high-risk group, is not known. Furthermore, in 
the absence of reliable biomarkers to assess adherence, 
the actual proportion of mothers who followed the 
dietary advice can only be estimated from patient-
reported dietary questionnaires. 
Currently in the USA and many other countries, 
pregnant women are recommended various weight 
gain targets during pregnancy according to their BMI 
status.6 In the UK, NICE (The National Institute for 
Health and Care Excellence) recommends referral of 
obese pregnant women to a dietician or a health-
care professional  but does not recommend regular 
weighing in pregnancy.7 Based on the UPBEAT study 
ﬁ ndings, a change in current UK guidelines is not 
needed. Women should be informed that although 
a healthy diet and lifestyle could minimise weight 
gain in pregnancy, there is no robust evidence for 
improvement in outcomes such as gestational 
diabetes or large-for-gestational-age babies. However, 
a reduction in excess weight gain in normal weight 
and overweight mothers has the potential to decrease 
postpartum weight retention and minimise the risk 
of beginning future pregnancies as obese individuals. 
Prevention of obesity needs to be prioritised equally 
with eﬀ orts to reduce complications in obese pregnant 
women. 
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Carolyn Chiswick and colleagues should be 
congratulated on their EMPOWaR study in The Lancet 
Diabetes & Endocrinology examining preventive medical 
intervention for improvement of fetal programming 
during pregnancy.1 The objective of this randomised, 
double-blind, placebo-controlled, trial,  was to establish 
whether metformin use led to improvements in 
maternal and fetal outcomes in obese pregnant women 
without diabetes, in particular in birthweight, which the 
investigators used as a surrogate marker for long-term 
adverse oﬀ spring outcome. Pregnant women with a 
BMI of 30 kg/m² or more and without diabetes received 
up to 2500 mg daily of metformin (n=223) or placebo 
(n=226) from 12 to 16 weeks’ gestation until delivery. 
Mean birthweight at delivery did not diﬀ er between the 
metformin group (3462 g [SD 548]) and the placebo 
group (3463 g [660]). The primary outcome of Z score 
of birthweight percentiles for babies delivered liveborn 
at 24 or more weeks’ gestation and standardised 
for sex, parity and gestation was similar between 
groups and the estimated eﬀ ect size of metformin on 
the primary outcome was non-signiﬁ cant (adjusted 
mean diﬀ erence of –0·029, 95% CI –0·217 to 0·158; 
p=0·7597). Furthermore, metformin had no eﬀ ect on 
prevention of gestational diabetes or maternal weight 
gain compared with placebo.
This well-designed study is one of the ﬁ rst clinical 
trials to investigate preventive treatment in pregnant 
women in hopes of providing protection for the 
unborn child from long-term adverse eﬀ ects later in 
life. The Barker hypothesis conceptualised the notion 
of fetal programming, claiming that the foundation 
for medical disorders encountered in childhood and 
adulthood are planted during fetal life.2 For instance, 
infants that have been exposed to hostile pregnancy 
environments, such as maternal hypertension 
leading to fetal growth restriction, are susceptible 
to developing cardiovascular disease, overt diabetes, 
and hypertension themselves as adults.3 Pregnant 
obese women inherently provide a similarly hostile 
pregnancy environment. These women are at risk 
of excessive gestational weight gain, development 
of gestational diabetes, and hypertension during 
pregnancy, including pre-eclampsia.4 Importantly, 
ﬁ ndings from previous studies have shown higher 
birthweights in oﬀ spring of obese women, which 
have been associated with childhood obesity.5,6 Thus, 
the vicious cycle of maternal obesity passing from 
generation to generation is perpetuated. 
Pregnancy as an opportunity to intervene and break 
this viscous cycle is an appealing option for all health-
care providers in perinatal medicine. The bold idea that 
Future research should investigate the association 
between clinical outcomes and weight gain within 
recommended targets for various BMI groups. Standar -
di sation of reporting of outcomes is required for 
meaningful interpretation of evidence, and clinical 
applicability of ﬁ ndings.
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